U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C32H44O8
Molecular Weight 556.687
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of CUCURBITACIN E

SMILES

CC(=O)OC(C)(C)\C=C\C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C=C(O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C

InChI

InChIKey=NDYMQXYDSVBNLL-MUYMLXPFSA-N
InChI=1S/C32H44O8/c1-17(33)40-27(2,3)13-12-23(36)32(9,39)25-21(35)15-29(6)22-11-10-18-19(14-20(34)26(38)28(18,4)5)31(22,8)24(37)16-30(25,29)7/h10,12-14,19,21-22,25,34-35,39H,11,15-16H2,1-9H3/b13-12+/t19-,21-,22+,25+,29+,30-,31+,32+/m1/s1

HIDE SMILES / InChI

Molecular Formula C32H44O8
Molecular Weight 556.687
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 8 / 8
E/Z Centers 1
Optical Activity UNSPECIFIED

Cucurbitacin E (CuE), a potent member of triterpenoid family isolated from plants, has been confirmed as an antitumor agent by inhibiting proliferation, migration, and metastasis in diverse cancer. Cucurbitacin E nhibits OS tumor growth and invasion through inhibiting the PI3K/Akt/mTOR signaling pathway. CuE can be considered to be a promising anticancer agent for OS. Cucurbitacin E exerts anti-inflammatory actions. It inhibited both COX enzymes with more selectivity toward COX-2. CuE has been reported to possess anti-inflammatory and anti-tumorigenic properties mediated by its action on the cellular cytoskeleton, on mitotic pathways as well as on cellular autophagy.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
The cucurbitacins E, D and I: investigation of their cytotoxicity toward human chondrosarcoma SW 1353 cell line and their biotransformation in man liver.
2013-02-04
Patents

Patents

Sample Use Guides

Cucurbitacin E was intra-peritoneally administered to mice at the dose of 30 and 60 mg/kg.
Route of Administration: Intraperitoneal
Cucurbitacin E at low concentrations (3-50 nmol/l) inhibited the growth of HL-60 cells, which was associated with G2/M cell-cycle arrest, decrease in the levels of cyclin-dependent kinase1, and increase in the levels of p21. Cucurbitacin E at high concentrations (1-10 mol/l) induced apoptosis of HL-60 cells and activation of caspase-3, caspase-8, and caspase-9
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:39:24 GMT 2025
Edited
by admin
on Mon Mar 31 21:39:24 GMT 2025
Record UNII
V8A45XYI21
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CUCURBITACIN E
MI  
Common Name English
NSC-106399
Preferred Name English
(-)-CUCURBITACIN E
Common Name English
.ALPHA.-ELATERIN
Common Name English
ALPHA-ELATERIN
Common Name English
CUCURBITACIN E [MI]
Common Name English
(9.BETA.,10.ALPHA.,16.ALPHA.,23E)-25-(ACETYLOXY)-2,16,20-TRIHYDROXY-9-METHYL-19-NORLANOSTA-1,5,23-TRIENE-3,11,22-TRIONE
Systematic Name English
.ALPHA.-ELATERINE
Common Name English
NSC-521775
Code English
19-NORLANOSTA-1,5,23-TRIENE-3,11,22-TRIONE, 25-(ACETYLOXY)-2,16,20-TRIHYDROXY-9-METHYL-, (9.BETA.,10.ALPHA.,16.ALPHA.,23E)-
Common Name English
CUCURBITACINE E
Common Name English
Code System Code Type Description
FDA UNII
V8A45XYI21
Created by admin on Mon Mar 31 21:39:24 GMT 2025 , Edited by admin on Mon Mar 31 21:39:24 GMT 2025
PRIMARY
NSC
106399
Created by admin on Mon Mar 31 21:39:24 GMT 2025 , Edited by admin on Mon Mar 31 21:39:24 GMT 2025
PRIMARY
CHEBI
3944
Created by admin on Mon Mar 31 21:39:24 GMT 2025 , Edited by admin on Mon Mar 31 21:39:24 GMT 2025
PRIMARY
EPA CompTox
DTXSID601030496
Created by admin on Mon Mar 31 21:39:24 GMT 2025 , Edited by admin on Mon Mar 31 21:39:24 GMT 2025
PRIMARY
PUBCHEM
5281319
Created by admin on Mon Mar 31 21:39:24 GMT 2025 , Edited by admin on Mon Mar 31 21:39:24 GMT 2025
PRIMARY
WIKIPEDIA
CUCURBITACIN E
Created by admin on Mon Mar 31 21:39:24 GMT 2025 , Edited by admin on Mon Mar 31 21:39:24 GMT 2025
PRIMARY
ECHA (EC/EINECS)
242-325-2
Created by admin on Mon Mar 31 21:39:24 GMT 2025 , Edited by admin on Mon Mar 31 21:39:24 GMT 2025
PRIMARY
NSC
521775
Created by admin on Mon Mar 31 21:39:24 GMT 2025 , Edited by admin on Mon Mar 31 21:39:24 GMT 2025
PRIMARY
MERCK INDEX
m3874
Created by admin on Mon Mar 31 21:39:24 GMT 2025 , Edited by admin on Mon Mar 31 21:39:24 GMT 2025
PRIMARY Merck Index
CAS
18444-66-1
Created by admin on Mon Mar 31 21:39:24 GMT 2025 , Edited by admin on Mon Mar 31 21:39:24 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY